Vaia Lambadiari
Welcome,         Profile    Billing    Logout  
 4 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lambadiari, Vaia
NCT05404295: The Effect of Treatment With Umbilical Cord Blood Platelet Lysate on Diabetic Foot Ulcers

Completed
4
120
Europe
Umbilical cord blood platelel lysate gel
Attikon Hospital, Biomedical Research Foundation, Academy of Athens
Diabetic Foot
06/22
03/23
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Active, not recruiting
3
2749
Europe, US, RoW
Orforglipron, LY3502970, Insulin Glargine
Eli Lilly and Company
Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease
09/25
01/26
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Active, not recruiting
3
15374
Europe, Canada, Japan, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Overweight
10/27
10/27
NCT05941910: The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function

Recruiting
2
60
Europe
Q10
Attikon Hospital
Non-Alcoholic Fatty Liver Disease
08/23
12/23
NCT04469582: The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors

Active, not recruiting
N/A
113
Europe
University of Athens
Bullous Pemphigoid
09/20
12/20
NCT06301191: The Effect of Semaglutide on Cardiovascular Markers and Liver Function

Recruiting
N/A
50
Europe
Semaglutide, 1.0 mg/mL, Dipeptidyl Peptidase 4 inhibitor
Attikon Hospital
Diabetes Type 2
03/23
05/24
NCT03878706: The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

Recruiting
N/A
240
Europe
University of Athens
Diabetes Mellitus, Type 2
12/26
06/27
NCT06646107: Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There a Difference

Not yet recruiting
N/A
240
Europe
MInimed 780G
Attikon Hospital
Type1diabetes
08/25
01/26

Download Options